|
Market Closed -
Australian S.E.
10:00:05 29/10/26 am AEDT
|
5-day change | 1st Jan Change | ||
| 0.0100 AUD | 0.00% |
|
-9.09% | -33.33% |
| 12/10 | Acrux Limited - Shareholder/Analyst Call | |
| 26/08 | Acrux Limited Reports Earnings Results for the Full Year Ended June 30, 2026 | CI |
| Market Cap | 5.9M 4.15M 3.72M 3.44M 3.12M 5.83M 395M 41.17M 16.4M 207M 15.58M 15.25M 657M | P/E 2025 |
-0.95x | P/E 2026 | -8.4x |
|---|---|---|---|---|---|
| Enterprise Value | 6.71M 4.72M 4.24M 3.92M 3.55M 6.63M 450M 46.85M 18.66M 235M 17.73M 17.35M 747M | EV / Sales 2025 |
2.07x | EV / Sales 2026 | 1.08x |
| Free-Float |
89.99% | Yield 2025 * |
-
| Yield 2026 | - |
Australian S.E.AUD
| Markets | Quality | ||
|---|---|---|---|
Australian S.E.
| ACR | Delayed | |
OTC Markets
| ARUXF | Delayed | |
Deutsche Boerse AG
| FJY | Delayed |
Last Transcript: Acrux Limited
| 23/05/22 | Acrux : Application for quotation of securities - ACR | PU |
| 14/04/22 | Acrux : Application for quotation of securities - ACR | PU |
| 16/03/22 | Acrux : Application for quotation of securities - ACR | PU |
| 25/02/22 | Acrux : Updated Board Charter | PU |
| 25/02/22 | Acrux : Application for quotation of securities - ACR | PU |
| 1 week | -9.09% | ||
| Current month | +11.11% | ||
| 1 month | +5.26% | ||
| 3 months | -9.09% | ||
| 6 months | -9.09% | ||
| Current year | -33.33% |
| 1 week | 0.01 | 0.01 | |
| 1 month | 0.01 | 0.01 | |
| Current year | 0.01 | 0.02 | |
| 1 year | 0.01 | 0.02 | |
| 3 years | 0.01 | 0.1 | |
| 5 years | 0.01 | 0.13 | |
| 10 years | 0.01 | 0.35 |
| Manager | Title | Age | Since |
|---|---|---|---|
John Warmbrunn
CEO | Chief Executive Officer | - | 01/06/2025 |
Joanna Johnson
DFI | Director of Finance/CFO | - | 21/06/2021 |
Jolanta Airey
CTO | Chief Tech/Sci/R&D Officer | - | 24/08/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Ross Dobinson
CHM | Chairman | 74 | 01/01/2006 |
Timothy Oldham
BRD | Director/Board Member | - | 01/10/2013 |
Geoff Brooke
BRD | Director/Board Member | 70 | 01/06/2016 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| 0.00% | -9.09% | -28.57% | -75.61% | 4.15M | ||
| +0.50% | +1.38% | +57.09% | +129.96% | 1,148B | ||
| +0.86% | +5.14% | +45.00% | +86.15% | 652B | ||
| -0.14% | +0.42% | +25.69% | +105.85% | 505B | ||
| +0.43% | +2.01% | +53.61% | +65.77% | 384B | ||
| -0.63% | -5.97% | +61.93% | +37.06% | 348B | ||
| +1.89% | +1.66% | +33.02% | +54.82% | 294B | ||
| +1.08% | -0.76% | +2.56% | +26.07% | 264B | ||
| +0.87% | +3.08% | +54.69% | +72.74% | 244B | ||
| +0.08% | +3.67% | +35.05% | +107.78% | 197B | ||
| Average | +0.51% | +1.25% | +34.01% | +61.06% | 403.72B | |
| Weighted average by Cap. | +0.53% | +1.50% | +44.75% | +88.95% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 4.49M 3.16M 2.83M 2.62M 2.37M 4.43M 301M 31.33M 12.48M 157M 11.86M 11.61M 500M | 6.58M 4.63M 4.16M 3.84M 3.48M 6.5M 441M 45.95M 18.3M 231M 17.39M 17.02M 733M |
| Net income | -5.94M -4.19M -3.75M -3.47M -3.14M -5.87M -399M -41.51M -16.53M -209M -15.71M -15.37M -662M | -604K -425K -381K -353K -319K -597K -40.5M -4.22M -1.68M -21.19M -1.6M -1.56M -67.27M |
| Net Debt | 2.77M 1.95M 1.75M 1.62M 1.47M 2.74M 186M 19.35M 7.71M 97.25M 7.32M 7.17M 309M | 813K 572K 513K 475K 430K 803K 54.51M 5.68M 2.26M 28.52M 2.15M 2.1M 90.55M |
Employees
43
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 29/10/26 | $0.0100 | 0.00% | 30,000 |
| 28/10/26 | $0.0100 | 0.00% | 464,443 |
| 27/10/26 | $0.0100 | 0.00% | 2,729,548 |
| 26/10/26 | $0.0100 | 0.00% | 7,120 |
| 23/10/26 | $0.0100 | -9.09% | 1,583,642 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- ACR Stock
Select your edition
All financial news and data tailored to specific country editions

















